Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anna Julie Kjøl, Tornes"'
Autor:
Monika Kvassheim, Anna Julie Kjøl Tornes, Asta Juzeniene, Caroline Stokke, Mona-Elisabeth R. Revheim
Publikováno v:
EJNMMI Physics, Vol 10, Iss 1, Pp 1-11 (2023)
1 Abstract Introduction 212Pb is a promising radionuclide for targeted alpha therapy. Here, the feasibility of visualising the tumour uptake and biodistribution of 212Pb-NG001 in mice with a clinical SPECT/CT scanner was investigated. Methods A mouse
Externí odkaz:
https://doaj.org/article/b81d3411ff9c4bfb8f2ff4f2ade245ba
Autor:
Anna Julie Kjøl Tornes, Vilde Yuli Stenberg, Roy Hartvig Larsen, Øyvind Sverre Bruland, Mona-Elisabeth Revheim, Asta Juzeniene
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Osteosarcoma patients with overt metastases at primary diagnosis have a 5-year survival rate of less than 20%. TP-3 is a murine IgG2b monoclonal antibody with high affinity for an epitope residing on the p80 osteosarcoma cell surface membrane antigen
Externí odkaz:
https://doaj.org/article/08e58ac533f34f7f8cbefaa9a9134bae
Autor:
Vilde Yuli, Stenberg, Anna Julie Kjøl, Tornes, Hogne Røed, Nilsen, Mona-Elisabeth, Revheim, Øyvind Sverre, Bruland, Roy Hartvig, Larsen, Asta, Juzeniene
Publikováno v:
Cancers. 14(11)
This study aimed to determine the influence of cellular PSMA expression, radioligand binding and internalization, and repeated administrations on the therapeutic effects of the PSMA-targeting radioligand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::390832c1cf26bd18faf300b9f7453533
https://pubmed.ncbi.nlm.nih.gov/35681766
https://pubmed.ncbi.nlm.nih.gov/35681766